Fact CheckerSign in

NCT07233044Completed

Effect of Visually-Guided Gait Training on Balance, Mobility and Risk of Falling in Patients With Multiple Sclerosis

Effect of Visually-Guided Gait Training on Balance, Mobility and Risk of Falling in Patients With Multiple Sclerosis: A Randomized Controlled Study

Source: ClinicalTrials.gov · Last updated 9 Jun 2026

Brief summary (registry, in English)

The aim of this study is to assess both immediate and long-term effects of visually-guided gait training on balance, mobility, and risk of falling in patients with multiple sclerosis.

Status (registry)
Completed
Study type
Interventional
Enrollment
40 (actual)
First submitted
14 Nov 2025
Start date
30 Nov 2025
Primary completion date
20 Apr 2026
Lead sponsor
Cairo University
NCT number
NCT07233044

What you commit to

  • Study type: Interventional
  • Participants enrolled: 40
  • From 30 Nov 2025 to the primary completion date, 20 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with severe cognitive impairment or psychological disorders impaired the ability to follow the procedures of the study.
  • Patients with cardiovascular and respiratory diseases.
  • Patients with serious unstable medical condition or Patients had an acute exacerbation of MS within last month.

Other

  • Patients with any other neurological deficits or orthopedics abnormalities.
  • Patients with secondary musculoskeletal complications such as fractures, contractures, or deformities.
  • Patients with vision problems that impaired walking ability.
  • Pregnant women.

Who the study is looking for

  • Clinically definite MS (relapsing and remitting) patients who are stable for at least three months.
  • Expanded Disability Status Scale (EDSS) score of ≤ 4 (fully ambulatory, self-sufficient, and able to stand and walk without any aid or orthosis at least 500 meters) to minimize the impact of motor weakness interfering with their ability to perform the task.
  • Normal or corrected to normal vision, wearing eyeglasses.
  • The age will range from 20 - 45 years.
  • All patients with MS were required to report subjective perceived imbalance or history of falls (in the last year)

Age in the registry: 20 years to 45 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kafrelsheikh University Hospital
Coordinator of this site? Confirm its status
Kafr ash ShaykhEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.